Celldex Therapeutics shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $156k | 4.6k | 33.98 |
| 2020-06-30 | $3.0M | 228k | 13.00 |
| 2020-03-31 | $496k | 299k | 1.66 |
| 2019-12-31 | $553k | 248k | 2.23 |
| 2019-09-30 | $546k | 256k | 2.13 |
| 2019-06-30 | $717k | 268k | 2.68 |
| 2019-03-31 | $723k | 147k | 4.92 |